Attack hard technology and serve all scenarios! See Yingkang’s “All in Health” from CMEF
From April 11th to 14th, the 89th China International Medical Equipment (Spring) Expo (“CMEF”) was held at the Shanghai National Convention and Exhibition Center. Nearly 5,000 brand companies from more than 30 countries and regions around the world brought tens of thousands of products. Products are on display. As a major health ecological brand under Haier Group, Yingkang Lifespan brought its latest innovative products and scenario solutions in the fields of life sciences and medical devices to CMEF, debuting breakthroughs in digital scenario solutions such as smart biological sample libraries, image enhancement, and chronic disease treatment. The results have attracted the attention of users and the industry.
From innovating key products with science and technology to creating digital and intelligent scenario solutions, Yingkang has continuously promoted the digital, intelligent and inclusive development of equipment and scenarios in the medical and health industry throughout its life, providing a new engine for the industry to build new quality productivity, and also taking practical actions to The industry and users have conveyed the determination and persistence of the brand “All in Health”.
Scientific and technological innovation tackles difficult problems, and new achievements are launched for the first time.
With the integration and development of technologies such as AI and the Internet of Things, the medical and health industry is accelerating innovation in the direction of personalization, precision, and digital intelligence. At this year’s CMEF, Yingkang Lifespan brought a number of “hard technology” achievements that were first exhibited for the first time. While creating the best experience for users, it also explored more possibilities for the digitalization and universalization of global medical care.
In the field of life sciences, we launched the country’s first precision management solution for biological risk samples and the industry’s first integrated distributed and expanded intelligent management solution to protect life science R&D and innovation with digital intelligence. Among them, the biological risk sample precision management solution is the first in the industry to create a new model of double-wing joint control sample management. By breaking through the in-box radio frequency positioning technology, radio frequency temperature reading technology, and sample intensive and accurate identification technology at a temperature of -80 degrees, users can operate in ultra-low temperature environments. Quick access, independent inventory, real-time monitoring, and precise control of every biological risk sample. The integrated distributed and expandable intelligent management solution brings users a flexible and scalable warehouse building experience, meets the simultaneous operation needs of multiple locations, multi-projects, and multi-tasks, and supports parallel operations of tube picking and full box delivery. At the same time, the solution is also equipped with an AI emergency safety assurance system, which can achieve fully automatic and rapid transfer with zero exposure to ensure sample safety.
In the field of image enhancement, the Discovery D series of high-pressure syringes launched at this exhibition have been innovatively developed around user needs and pain points, and have been completely upgraded in terms of applicable scenarios, intelligence, and safety. The product is equipped with patented technologies such as the world’s original “direct pressure sensor”, which can detect injection pressure and handpiece angle in real time to protect patient safety. In addition, product innovation adopts wireless design, and realizes information exchange and automatic injection of patients, contrast agents, etc., making medical and nursing operations more convenient and safer.
Improve the quality of digital intelligence scenarios and diversify user services
At the Yingkang Life Science booth, the digital scenario solutions for the three major scenarios of smart laboratories, smart hospitals, and smart healthy cities were displayed on site, using new technologies, new services, and new experiences to demonstrate the development of “new” and “smart” Improved scientific and technological innovation capabilities help the medical and health industry flourish.
At the exhibition site, you can see the three major technologies based on self-developed 3D-AI visual recognition self-learning, multi-manipulator bionic control, and high-speed motion control. Haier Biomedical provides outpatient/emergency care, hospitalization, operating rooms, wards, static distribution centers, etc. The entire in-hospital drug use scenario has been upgraded with digital intelligence, realizing digital closed-loop management of the entire process of drug “deposit, transfer, distribution and use”, helping the hospital achieve full traceability of drug use information, full transparency of drug circulation information, and full management of intelligent equipment operation.
Facing the diversified needs of different users, Haier Biomedical has brought a full-scenario digital solution for smart laboratories based on the digital twin system, including eight major scenario solutions such as cell culture laboratory, animal laboratory, microbiology laboratory, and sample storage. Automation, intelligence, Internet of Things, and shared management promote the upgrade of life science R&D and production models to automation, high-throughput, and intelligence.
In response to the health needs of different groups, from cities to communities to families, Haier Biomedical has also created diversified health services such as vaccination, clinical blood, health examinations, and maternal and child health care. For example, in order to improve the safety of vaccination, Haier Biomedical brings a smart vaccine full-scenario solution to achieve accurate vaccine collection with zero errors, freeze problematic vaccines in seconds, and trace the entire vaccination process; in order to help the elderly enjoy a happy and happy later life, the company has implemented “in-hospital +” “Outside the hospital” physical examination IoT system, opening up the “last mile” of health services for the elderly; in order to protect the health of maternal and child groups, innovative smart maternal and child solutions, multi-terminal interconnection to achieve high integration of the full cycle of pregnancy and the full cycle of immunization planning; targeting communities and families in the city The smallest “cell” creates smart mobile medical solutions covering vaccinations, physical examinations for the elderly, and “two cancer” screenings for women…
Powerful products appear in key scenes and make breakthroughs
As a strategic emerging industry that my country focuses on supporting, the medical device industry covers high-end manufacturing on one end and links to national medical health on the other end. It is one of the key areas in shaping new productivity. At this exhibition, Yingkang Lifespan’s full range of medical devices were unveiled in six scenarios: female care scenarios, radiotherapy, life support, image enhancement, chronic disease treatment, and digital intelligent management platforms, including large-scale stereotactic radiosurgery treatment equipment. A number of innovative medical equipment such as MAKI, a full range of precision infusion products, digital breast machines, a full range of CT/MRI/DSA high-pressure syringe products, cover multiple key scenarios inside and outside the hospital.
The key to caring for women’s health lies in the “three early mornings”: early detection, early diagnosis and early treatment. At the exhibition site, the third-generation digital mammography X-ray photography system attracted a large number of visitors to stop and watch. This digital breast machine is also known as the “strongest weapon” in early breast cancer screening and is an important equipment for early breast cancer screening. Through innovative technology, this product can clearly display calcified lesions smaller than 0.2mm, improving the accuracy of breast imaging in identifying benign and malignant lesions. It is understood that the third-generation digital mammography X-ray imaging system has a lesion detection rate as high as 93%, and a benign and malignant accuracy rate as high as 94%.
In life support scenarios, hospital-wide smart infusion solutions based on 5G IoT systems have become a hot topic. Based on a full range of infusion products covering ICU, anesthesia, neonatal, obstetrics and gynecology, operating room and other departments, the infusion products of each department are centralized managed through digital methods, supporting access to HIS/CIS systems to open up infusion The equipment’s information island is integrated into the hospital’s larger ecology, improving infusion safety and work efficiency while providing an overall solution for hospital infusion therapy information management.
In the radiotherapy scene, Yingkang Lifespan Medical Equipment exhibited its independent intellectual property rights “radiotherapy artifact” for brain tumors – the SRRS+ head gamma knife. The accuracy of the equipment reaches nearly three times the international standard, representing the cutting-edge level of stereotactic radiotherapy today. This product has successfully broken the overseas monopoly and “exported overseas” to the United States, Europe, Asia, Latin America and other countries and regions, becoming one of the representative breakthroughs of domestic enterprises in medical equipment in this field.
Faced with the current dual role of the continuous upgrading of people’s health needs and the intelligent empowerment of science and technology, in the future, Yingkang Lifespan will adhere to the vision of “Everyone in the world lives with Yingkang”, focusing on user needs, while deeply cultivating independent technological innovation, and at the same time integrating Scenario-based digital intelligence services will in-depth explore and accelerate innovation in key areas and key equipment to create a new open, shared, and inclusive medical health ecosystem, and contribute to the construction of new productivity in the medical industry.
